Article Details

Therapeutic Frontiers Expand for Patients With Relapsed/Refractory Multiple Myeloma - OncLive

Retrieved on: 2021-12-06 16:39:21

Tags for this article:

Click the tags to see associated articles and topics

Therapeutic Frontiers Expand for Patients With Relapsed/Refractory Multiple Myeloma - OncLive. View article details on hiswai:

Excerpt

... monoclonal antibodies, and, more recently, chimeric antigen receptor T-cell therapy and bispecific antibodies for T-cell redirection.

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up